Viewing Study NCT00868361


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-01-25 @ 6:00 PM
Study NCT ID: NCT00868361
Status: TERMINATED
Last Update Posted: 2009-09-16
First Post: 2009-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module